前列腺癌
谷氨酸羧肽酶Ⅱ
单克隆抗体
前列腺
分子成像
医学
靶向治疗
癌症研究
癌症影像学
癌症
抗体
内科学
免疫学
生物
体内
生物技术
作者
В. К. Тищенко,Василий Михайлович Петриев,Оксана Петровна Власова,В. В. Крылов,П. В. Шегай,С. А. Иванов,А. Д. Каприн
标识
DOI:10.1134/s106377882209037x
摘要
Abstract Molecular changes in prostate cancer lead to increased expression of prostate-specific membrane antigen (PSMA), which is a suitable target for imaging and therapy using radiopharmaceuticals. Data on the most effective clinically significant PSMA radiopharmaceuticals for the diagnosis and treatment of prostate cancer are summarized. The advantages and disadvantages of ligands based on monoclonal antibodies and their fragments as well as small molecular PSMA inhibitors are discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI